News - MedTech & Diagnostics
Australia’s $9 billion diabetes bill sparks health check push
The type 2 diabetes epidemic is imposing a far greater toll on the health system than previously understood, with new […]
MoreNews - Biotechnology
Australia’s IP trends reveal post-pandemic innovation shift
Australia’s life sciences sector continues to evolve amidst a dynamic landscape of intellectual property (IP) rights, particularly patents, which are […]
MoreNews - Pharmaceuticals
Pfizer and Novo Nordisk join calls for prevention framework as Australia lags behind peer nations
Despite overwhelming evidence supporting the value of prevention, governments remain reluctant to lead investment in long-term health strategies. Submissions from […]
MoreNews - Biotechnology
CSL reshapes R&D while bracing for U.S. tariffs
Australia’s largest biotech company CSL is streamlining its R&D operations to enhance efficiency amidst a rapidly evolving global landscape. The […]
More